FDA Warning Statin Drugs Linked to Interstitial Lung Disease

Statin drugs lower the level of cholesterol in the blood by decreasing the production of cholesterol by the liver. Statins work by blocking hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), the enzyme in the liver that is responsible for producing cholesterol. Although cholesterol is essential to the […]

Nov 21, 2017

FDA Warns Cholesterol Lowering Statin Drugs Can Cause Interstitial Lung Disease
FDA Warning Tanzeum linked to Anaphylaxis Reaction

Tanzeum Tanzeum (albiglutide) is an injectable diabetes medication that was approved by the U.S. Food and Drug Administration (FDA) in 2014. A glucagon-like peptide (GLP-1) receptor agonist, Tanzeum is used, along with diet and exercise, to help control blood sugar levels in those with type […]

Nov 21, 2017

Tanzeum (albiglutide) Discontinued After FDA Warns Of Risk Of Anaphylaxis Reaction